Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Enzo Biochem Inc. (ENZ)

-NYSE
4.29 Down 0.02(0.46%) 4:05PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJan 31, 2014Oct 31, 2013Jul 31, 2013Apr 30, 2013
Total Revenue 22,927   24,134   23,270   22,598  
Cost of Revenue13,158  13,555  13,823  13,550  
Gross Profit 9,769   10,579   9,447   9,048  
Operating Expenses
Research Development832  817  921  989  
Selling General and Administrative10,083  10,529  10,314  11,032  
Non Recurring2,408  2,253  1,602  2,636  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (3,554) (3,020) (3,390) (5,609)
Income from Continuing Operations
Total Other Income/Expenses Net35  358  (169)(189)
Earnings Before Interest And Taxes(3,571)(2,724)(3,559)(5,783)
Interest Expense -   -  (25)25  
Income Before Tax(3,571)(2,724)(3,534)(5,808)
Income Tax Expense(5)63  (432)(38)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,566)(2,787)(3,102)(5,770)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,566) (2,787) (3,102) (5,770)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,566) (2,787) (3,102) (5,770)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.